Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Almac Group
Biotech
Merck taps Almac in neurodegenerative drug discovery deal
Merck struck an R&D pact with Almac Discovery centered on deubiquitinases, a family of enzymes that play many roles in cellular regulatory processes.
Amirah Al Idrus
Apr 29, 2020 9:00am
TP taps Almac to develop repotrectinib companion diagnostic test
Oct 26, 2018 11:00am
Chutes & Ladders—Gilead's 2 top executives step down
Jul 27, 2018 8:00am
Chutes & Ladders—Bob Hugin retires as Celgene's executive chair
Feb 2, 2018 2:41am
Almac Discovery, RCSI form anticancer stem cell R&D pact
Feb 14, 2017 6:59am
Almac Group boosts U.S. footprint with new jobs, investment
Sep 22, 2016 3:31am
